24 results
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
company in South San Francisco, as Head of Global Oncology Launch Excellence and Biosimilar Strategy and Head of Global Product Strategy for Immunology … strategy, potential modifications to that strategy and new trends, plans or approaches to compensation. Generally, the Compensation Committee’s process
8-K
EX-99.1
pvteg
5 Jan 22
Regulation FD Disclosure
4:02pm
DEF 14A
iimh85j
14 Apr 21
Definitive proxy
7:00am
10-K
6m2g174 hd12
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
fkysskqnyw9h
5 Jan 21
Results of Operations and Financial Condition
4:31pm
10-Q
m81vw2x4qmi
11 Dec 20
Quarterly report
7:30am
424B4
vl8no f9m
30 Oct 20
Prospectus supplement with pricing info
4:31pm